Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Chewing Gum Effect in Reducing Orthodontic Pain After Separator and Initial Arch Wire Placement

5. april 2021 oppdatert av: University of Malaya

The Effect of the Chewing Gum in Alleviating Orthodontic Pain After Separator and Initial Arch Wire Placement: A Randomized Clinical Trial

Pain is the most claimed complaint from orthodontic treatment. Fear of pain has contributed to patients' avoidance of seeking orthodontic treatment, affects patients' compliance to treatment and even becomes the main reason for discontinuing orthodontic treatment. For years, orthodontic patients have reported using analgesics during orthodontic treatment to ease the pain. However, analgesics have many side effects such as allergic reactions, bleeding disorders, gastric ulcers, liver toxicity and their potential influence in slowing down tooth movement. This study aimed to investigate the effectiveness of chewing gums in pain reduction in Malaysian multi-ethnic orthodontic patients and to explore the possibility of chewing gum to be recommended as a suitable substitute for analgesics in our future practice.

Studieoversikt

Status

Rekruttering

Detaljert beskrivelse

Orthodontic treatment have been shown to cause varying degrees of discomforts and pain to the patients. Fear of pain has contributed to patients' avoidance of seeking orthodontic treatment, affect patients' compliance to the treatment and even become a main reason of discontinuing orthodontic treatment. Patients have reported using of analgesic particularly NSAIDS and Paracetamol during orthodontic treatment to ease the pain. However, NSAIDS have been associated with various side effects such as allergic reactions, bleeding disorders and gastric ulcers had raised the concern of orthodontists. Studies on animals have shown that NSAIDS slower the rate of tooth movement, hence affecting orthodontic treatment efficacy. Paracetamol have been reported to cause liver toxicity in the case of over dosage.

The action of chewing the gum can produce forces to temporary displace the teeth sufficiently to allow blood flow through compressed area, preventing the build-up of metabolic products, thus reduce the pain severity. In addition, non-sugared chewing gum has anti-caries effect which is very important to prevent caries formation during orthodontic treatment.

This study aimed to investigate the effectiveness of chewing gum in pain reduction in orthodontic patients and to explore the possibility of chewing gum to be recommended as a suitable substitute for analgesics in future practice.

Studietype

Intervensjonell

Registrering (Forventet)

108

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Wilayah Persekutuan Kuala Lumpur
      • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia, 50603
        • Rekruttering
        • Postgraduate Orthodontic Clinic, Faculty of Dentistry, University Malaya
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

16 år og eldre (Barn, Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Patients about to undergo orthodontic treatment with maxillary and mandibular fixed appliances
  2. Orthodontic treatment include the extraction of the permanent first or second premolars
  3. Age 16 years and above

Exclusion Criteria:

  1. Significant medical problem or cleft lip and palate.
  2. Pregnant lady
  3. Occurrence of using analgesics or antibiotics
  4. History of asthma or unstable asthma the last year
  5. Oral surgery in the previous 4 weeks

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: intervention group
Participants will receive Wrigley Extra Strawberry Flavour Sugar Free Chewing Gum. They will be instructed to chew the gum for pain relief after the separator and initial arch wire placement if required. Chew the gums for 10-12 minutes and as much as they want whenever they feel discomfort or pain. They are free to take any medication when necessary and respond to the questionnaires on the amount of chewing gum and analgesics used.
Wrigley Extra Strawberry Flavour Sugar Free Chewing Gum 65g 40 pieces
Ingen inngripen: Control group
Participants will not receive any prescription after the separators and initial arch wires placement. They will be specifically asked not to chew chewing gum. As in the intervention group, they can take any medication when they feel necessary and respond to the questionnaires on the amount of analgesics used.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pain assessment after separators and initial arch wire placement.
Tidsramme: At 6 hours after separators and initial arch wire placement.
Level of pain on the Numerical pain rating scale (NRS)
At 6 hours after separators and initial arch wire placement.
Pain assessment after separators and initial arch wire placement.
Tidsramme: At 24 hours after separators and initial arch wire placement.
Level of pain on the Numerical pain rating scale (NRS)
At 24 hours after separators and initial arch wire placement.
Pain assessment after separators and initial arch wire placement.
Tidsramme: At 48 hours after separators and initial arch wire placement.
Level of pain on the Numerical pain rating scale (NRS)
At 48 hours after separators and initial arch wire placement.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Reported use of chewing gum and analgesics.
Tidsramme: Immediately after the separator and archwire placements until up to 6 hours
Amount of chewing gums and medications consumed after the separator and initial arch wire placement
Immediately after the separator and archwire placements until up to 6 hours
Reported use of chewing gum and analgesics.
Tidsramme: from 6 hours to 24 hours after the separator and archwire placements
Amount of chewing gums and medications consumed after the separator and initial arch wire placement
from 6 hours to 24 hours after the separator and archwire placements
Reported use of chewing gum and analgesics.
Tidsramme: from 24 hours to 48 hours after the separator and archwire placements
Amount of chewing gums and medications consumed after the separator and initial arch wire placement
from 24 hours to 48 hours after the separator and archwire placements
Recorded appliances breakages.
Tidsramme: Immediately after the separator and archwire placements until 2 days after the separator and archwire placement
Frequency of appliances breakages
Immediately after the separator and archwire placements until 2 days after the separator and archwire placement

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: Siti Adibah Othman, Prof, Faculty Of Dentistry, University of Malaya
  • Studieleder: Zamros Yuzadi Mohd Yusof, Prof, Faculty Of Dentistry, University of Malaya
  • Hovedetterforsker: Poon Pei San, Faculty Of Dentistry, University of Malaya

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

6. mars 2019

Primær fullføring (Forventet)

1. august 2021

Studiet fullført (Forventet)

1. august 2021

Datoer for studieregistrering

Først innsendt

5. november 2020

Først innsendt som oppfylte QC-kriteriene

5. april 2021

Først lagt ut (Faktiske)

8. april 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

8. april 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

5. april 2021

Sist bekreftet

1. april 2021

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • DGD170001

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere